Live Agbiotech updates

Live Agbiotech news coverage of developments with the latest updates. Stay on top of latest Agbiotech news stories and find out what just happened, what is going on with Agbiotech. The latest real-time news updates and headlines on Agbiotech
Immunoglobulin Sales Drive Strong First Half For CSL
AdvanCell, Lilly Team Up for Novel Alpha Therapies
US University Joins Chimeric's CHM CDH17 Clinical Trial
Argenica: ARG-007 Cuts Brain Cell Damage in Study
AdvanCell Closes Oversubscribed Series C Round
Noxopharm's SOF-SKN Clears Vital Safety Tests
AusBiotech, MTPConnect Push to Boost Life Sciences
AusBiotech Hails Members in Australia Day Honours
Immutep Finalizes EFTISARC-NEO Phase 2 Enrollment
Neuren Partner Files Trofinetide EU Marketing Bid
Vaxxas Wins US Prize for Vaccine Patch Innovation
Race Oncology Appoints Opthea Founder To Its Board
2024 Report: Boosting Australia's Cell & Gene Sector
Immutep, Monash Reveal LAG-3 Binding to MHC Class II
Medtech Alliance Welcomes New Steering Group Members
Seeking Member Inputs: April 2025 Australasian BioJournal
AusBiotech And BioNSW Sign MOU To Deepen Collaboration
AusBiotech, BioMelbourne Hail Victoria's Growth Plan
FivepHusion Gets Green Light for Phase 1b Trial
Recce Gains Indonesia Nod for Phase 3 Trial
AusBiotech Celebrates ESIF Winners
Orthocell Hits All Endpoints in Nerve Repair Trial
AusBiotech Welcomes Government's Review Of R&D
AusBiotech Welcomes New Board Director
Biotech & Medtech Summit: Key Outcomes Revealed
Biotech & Medtech Summit: Key Outcomes Announced
AusBiotech Hails New HTA Advisory Group Launch
Digital Project Unveils Medical Research Careers
Race Oncology Unveils New FTO Inhibitor Candidates
Neurizon Drug Cuts ALS Target Aggregation
AdAlta Appoints Two New Non-Executive Directors
AusBiotech, MTPConnect Host Inaugural Life Sciences Summit
Amplia Begins Preclinical Work With Korean Firm
AusBiotech Announces Inaugural Depaz Oration
AusBiotech And MTPConnect Launch Joint Discussion Paper On Critical Life Science Growth Issues Ahead Of National Summit
Optiscan, Monash Unite to Advance GI Scope
Recce Reaches Final Dosing in Phase 2 Trial
Imugene: Bile Cancer Patient Maintains Full Response
Chimeric Secures Funds for CHM CDH17 Development
Top Ministers to Speak at Australia's Biggest Biotech Week
Immuron Reports Continued Sales Growth For Travelan
Respiri Secures Major Strategic Investment
AusBiotech Announces 2024 Board Election
Chimeric Cancer Patient Sees Full Response In Trial
Health Minister to Speak at Australia's Biotech Week
Mesoblast Secures Option for $50M Convertible Notes
PolyNovo Non-exec Director Retires
Percheron Therapeutics Updates Avicursen Primate Study